The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost of recurrence among patients with HR+/HER2- metastatic breast cancer.
 
Nicole M. Engel-Nitz
Stock and Other Ownership Interests - UnitedHealthcare
Research Funding - Alexion Pharmaceuticals (Inst); Amgen (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genoptix (Inst); GlaxoSmithKline (Inst); Novartis (Inst); ZIOPHARM Oncology (Inst)
 
Laura Becker
Stock and Other Ownership Interests - UnitedHealthcare
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Covidien (Inst); Depomed (Inst); Eisai (Inst); GE Healthcare (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); HDL Pharma (Inst); Janssen Biotech (Inst); Lilly (Inst); MedImmune (Inst); Medtronic (Inst); Mylan (Inst); Novartis (Inst); Sanofi (Inst); Shire (Inst); The Medicines Company (Inst)
 
Randall Gerdes
Stock and Other Ownership Interests - UnitedHealthcare
Research Funding - Actelion (Inst); Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Genoptix (Inst); Genzyme (Inst); GlaxoSmithKline (Inst); Grifols (Inst); Janssen-Ortho (Inst); Lilly (Inst); Novartis (Inst); Novo Nordisk (Inst); Pfizer (Inst); Sanofi (Inst); Shire (Inst)
 
Yanni Hao
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Research Funding - Novartis